Related Articles

Brand Name Analysis
Drug Experts
Drug Labeling 1
Drug Labeling 2
Drug Labeling 3
Drug Labeling 4
Drug Name Review
Drug Packaging
Drug Packaging 2
Drug Safety
Drug Safety 2
Effect Analysis
FDA Report
FMEA
FMEA
Generic Drugs
Health Canada Report
Health Canada Report
Look Alike
Medication Safety
Medication Error
Medication Error
Post-marketing Risk Assessment
Risk Minimization
Safe Medication Practices
Stigmatized Diseases

More Articles

 

The FMEA Process

The objective of a FMEA is to look for any and all ways a product or process can fail. It starts with the assumption that something can and will go wrong, so let's fix it before it does. Even the simplest products can fail, or the user can make a mistake.

Failure modes are ways in which a process or product can fail. Each failure mode has a potential effect, and some are more likely to occur than others. Each potential effect has an associated relative risk. The FMEA process is a way to identify the failures, effects, and risks, and then reduce or eliminate them.

Three factors determine the relative risk of a failure and its effects. First is severity of the consequence of failure, should it occur. Second is the probability or frequency of the failure occurring, or occurrence. Third is detection, or the probability of the failure being detected before a negative impact is realized.


  Related Links

  - FDA
  - FDA MedWatch
  - FDA (AERS)
  - USP
  - Health Canada
  - EMEA
  - NCC MERP
 

   
 
     
     
  Home  |  About Us  |  Proprietary Naming  |  NonProprietary Naming  |  Labeling & Packaging  |  Risk Management  |   News  |  Contact Us
  Copyright © 2005 Drug Safety Institute. All Rights Reserved.